James H. Stanker - 05 Apr 2024 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Financial Officer
Signature
/s/ James H. Stanker by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
05 Apr 2024
Net transactions value
-$1,927
Form type
4
Filing time
02 Aug 2024, 17:31:53 UTC
Previous filing
12 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +1,675 +34% 6,638 05 Apr 2024 Direct F1
transaction PCSA Common Stock Tax liability $1,445 -518 -7.8% $2.79 6,120 05 Apr 2024 Direct
transaction PCSA Common Stock Options Exercise +644 +11% 6,764 10 Jul 2024 Direct F1
transaction PCSA Common Stock Tax liability $482 -282 -4.2% $1.71 6,482 10 Jul 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Units Award $0 +3,077 +13% $0.000000 26,470 28 Jun 2024 Common Stock 3,077 $0.000000 Direct F2
transaction PCSA Restricted Stock Units Award $0 +2,307 +8.7% $0.000000 28,777 28 Jun 2024 Common Stock 2,307 $0.000000 Direct F3
transaction PCSA Restricted Stock Units Award $0 +385 +1.3% $0.000000 29,162 28 Jun 2024 Common Stock 385 $0.000000 Direct F4
transaction PCSA Restricted Stock Units Award $0 +385 +1.3% $0.000000 29,547 28 Jun 2024 Common Stock 385 $0.000000 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of vested restricted shares.
F2 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on January 1, 2025.
F3 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2025, and one-thirty-sixth each month thereafter until fully vested on January 1, 2027.
F4 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals.